AIM ImmunoTech Inc.
AIM
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.00K | 45.00K | 35.00K | 50.00K | 40.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.00K | 45.00K | 35.00K | 50.00K | 40.00K |
| Cost of Revenue | 10.00K | 7.00K | 8.00K | 8.00K | 8.00K |
| Gross Profit | 6.00K | 38.00K | 27.00K | 42.00K | 32.00K |
| SG&A Expenses | 2.65M | 4.32M | 3.08M | 2.59M | 3.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.64M | 5.90M | 4.52M | 3.74M | 5.77M |
| Operating Income | -3.62M | -5.86M | -4.49M | -3.69M | -5.73M |
| Income Before Tax | -3.71M | -5.97M | -3.70M | -1.84M | -5.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.71M | -5.97M | -3.70M | -1.84M | -5.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.71M | -5.97M | -3.70M | -1.84M | -5.82M |
| EBIT | -3.62M | -5.86M | -4.49M | -3.69M | -5.73M |
| EBITDA | -3.56M | -5.79M | -4.43M | -3.63M | -5.68M |
| EPS Basic | -5.32 | -9.41 | -6.48 | -3.51 | -11.88 |
| Normalized Basic EPS | -3.35 | -5.70 | -4.35 | -2.09 | -7.31 |
| EPS Diluted | -5.32 | -9.41 | -6.48 | -3.51 | -11.88 |
| Normalized Diluted EPS | -3.35 | -5.70 | -4.35 | -2.09 | -7.31 |
| Average Basic Shares Outstanding | 71.03M | 64.65M | 58.25M | 53.37M | 49.95M |
| Average Diluted Shares Outstanding | 71.03M | 64.65M | 58.25M | 53.37M | 49.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |